Recent advancements in HAE treatments offer hope, but experts stress the need for more pediatric options and diverse therapies.
Daniel Soteres, MD, PhD
Advertisement
Daniel Soteres, MD, PhD: University of Colorado Health Sciences Center
Articles by Daniel Soteres, MD, PhD
A study presented at ACAAI 2025 reveals HAE attacks may start in toddlers, highlighting significant daily burdens and the importance of timely diagnosis and treatment.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
FDA Approves Olezarsen (Tryngolza) for Severe Hypertriglyceridemia
2
Q&A: CKM Care, IRA Policy, and Specialty Silos, With Rishi Wadhera, MD, MPP, MPhil
3
Delgocitinib Approval Fills a Long-Standing Gap in Chronic Hand Eczema Treatment
4
ILD as a Cardiopulmonary Disease: Cardiology's Role in Management
5